399 results
Page 6 of 20
D
1ajm2 23ouuav8x
19 Dec 19
$26.42M in equity / options, sold $26.42M, 5 investors
4:30pm
8-K
5dbvecobmdcsoy8
11 Dec 19
Regulation FD Disclosure
4:48pm
8-K
EX-10.2
1y02vo
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
3ee6crs
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
EX-99.1
84n 9oo2x2o1j4w1
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
EX-99.1
zmd7o1
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
DEF 14C
r0wo0
18 Jul 19
Information statement
4:49pm
PRER14C
bkc59w16g5 tqel
17 Jul 19
Preliminary revised information
5:29pm
PRE 14C
e4v2g5asjp3z5
24 Jun 19
Preliminary information
4:25pm
8-K
EX-99.1
hhkvb
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
8-K
EX-99.1
yr5 1tseqnjyl
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm